Alexandria faculty of medicine
Alexandria, 21500, Egypt
NCT Number: NCT04640454
Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is a form of mastectomy that achieves optimal disease control and facilitates reconstruction. The study aimed to assess the oncological safety and aesthetic outcomes of nipple-sparing mastectomy and immediate breast reconstruction.
35 female patients with breast cancer were included in the study. The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.
Looking for future studies?
Notify Me28 year–68 year
Female
Observational
Alexandria, 21500, Egypt
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.
Time frame: 2017-2019
Complete general examination, local examination of the skin, nipple and areola were done to determine whether the patients suffered from any complaints
Time frame: 2017-2019
Alexandria University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06234488
Breast Adenocarcinoma, Breast Cancer
Los Angeles, California, United States
View Trial DetailsNCT03949946
Breast Cancer, Breast Diseases
Aberdeen, Aberdeenshire, United Kingdom
View Trial DetailsNCT05176860
Breast Cancer, Breast Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT03644186
Breast Cancer, Breast Diseases
Brasschaat, Belgium
View Trial Details